Truly a ”Care Team Forum®,” this roundtable discussion brings together a leading team of experts from a multidisciplinary atopic dermatitis (AD) clinic to talk about best practices in the treatment of pediatric AD. The panel is joined by a mother of a preteen daughter with severe AD who details her journey with multiple atopic disorders since infancy. The team discusses updates in the understanding of the pathophysiology of AD, the atopic march, updates in the treatment of pediatric AD, and exciting treatment options on the horizon. They also share how they coordinate care in between members of their interprofessional and multidisciplinary team.
Upon completion of this activity, participants should be better able to:
Voluntary Associate Clinical Professor, Allergy & Immunology
Co-Director, AAFA-sponsored Severe Asthma Program
Rady Children’s Hospital
Allergy/Immunology Director, Multidisciplinary Atopic Dermatitis Program
University of California San Diego
President, San Diego Allergy Society
San Diego, CA
Eczema Educator/Lead Clinical Research Coordinator
Rady Children’s Hospital
Director, Grants and Rare Disease
Allergy and Asthma Medical Group and Research Center
Executive Director, San Diego Allergy Society
San Diego, CA
Assistant Professor, Department of Dermatology
University of California San Diego
San Diego, CA
Clinic Coordinator, Multidisciplinary Atopic Dermatitis Program
Rady Children’s Hospital
San Diego, CA
Resources
RMEI Medical Education, LLC (RMEI) requires instructors, planners, managers, and others in control of educational content to disclose all their financial relationships with ineligible companies over the previous 24 months. All identified financial relationships are thoroughly vetted and mitigated according to RMEI policy.
Bob Geng, MD, has relevant financial relationships with ADMA Biologics Inc., AstraZeneca, BPL, Chiesi USA, Inc., Galderma, Kenota Health, Leo Pharma, Novartis, Pharming, Quest (Consultant); ADMA Biologics Inc., Chiesi USA, Inc., Incyte Corporation, Sanofi, X4 Pharmaceuticals, Inc. (Grant/Research Support); AbbVie, BioCryst Pharmaceuticals, Inc., GlaxoSmithKline, Grifols, Horizon, OptiNose, Pfizer, Regeneron, Sanofi, Takeda (Speakers/Speaker’s Bureau).
Lauren Loop, has no relevant financial relationship(s) with ineligible companies to disclose.
Reid Oldenburg, MD, PhD, has relevant financial relationships with AbbVie (Research Support).
Katie Smiley, PA-C, has no relevant financial relationship(s) with ineligible companies to disclose.
Caregiver (Christy) participating in this activity has no relevant financial relationship(s) with ineligible companies to disclose
All of the relevant financial relationships listed for these individuals have been mitigated according to RMEI policies.
RMEI Medical Education, LLC planners and managers have no relevant financial relationship(s) with ineligible companies to disclose.
In support of improving patient care, RMEI Medical Education, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
RMEI Medical Education, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour(s).
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 medical knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.
In order to receive credit, participants must review the activity content and successfully complete both the post-test and evaluation. You must score 75% or higher on the post-test to receive credit for this activity. If you have questions about this activity, please contact RMEI at [email protected].
Users must;
In order to claim MOC points, users must
Note: RMEI Medical Education, LLC will share completion information with ABIM via ACCME’s Program Activity Reporting System (PARS).
There is no fee to participate.
COMPLETE THE EVALUATION FORM AND YOU WILL BE ENTERED INTO A DRAWING
FOR A $100* AMAZON GIFT CARD!*
*The expense for this gift card is solely funded by RMEI Medical Education, LLC.
No supporter funding was used for the expense of this gift card.
Rules and Regulations
This sweepstakes is managed by RMEI Medical Education, LLC (RMEI), a jointly accredited provider. The winner will be selected via automated random drawing on a quarterly basis from among all eligible entries and notified through the contact information provided. In accordance with our privacy policy, we do not share your information with any third parties. By entering the sweepstakes, you grant RMEI permission to use your e-mail address to reach you for notification and prize fulfillment. Only individuals who complete the evaluation forms and provide contact information will be eligible to win. Open to those who have a US postal address and who are 18 years or older. Only one prize per person and per household will be awarded. The prize will be a $100 Amazon gift card.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Featured RMEI CE Activities
Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources
